120
Participants
Start Date
February 11, 2025
Primary Completion Date
September 1, 2027
Study Completion Date
September 1, 2027
Adherence measured by MEMS caps
The methodological choices made in this study are justified by the need to assess the effectiveness of bictegravir, taking into account the varying levels of adherence among PLHIV. The use of electronic antiretroviral caps (MEMS caps: https://aardexgroup.com/medication-event-monitoring-system/ ) and the intra-cellular TAF assay to measure drug concentrations will enable a combined, precise and objective assessment of treatment adherence, and constitute the originality of this research.
RECRUITING
CHU de Caen, Caen
NOT_YET_RECRUITING
CHU de Nantes, Nantes
RECRUITING
CHU d'Orléans, Orléans
NOT_YET_RECRUITING
Hôpitaux Civils de Lyon, Lyon
NOT_YET_RECRUITING
CHU Pitié-Salpétrière, Paris
NOT_YET_RECRUITING
CH de Niort, Niort
NOT_YET_RECRUITING
CHD Vendée, La Roche-sur-Yon
NOT_YET_RECRUITING
CHU de Poitiers, Poitiers
Hôpital Côte de Nacre, CHU de Caen
UNKNOWN
Association pour la promotion de la recherche en maladies infectieuses et tropicales dans le Loiret
OTHER